Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
about
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancersRegulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in CancerRon receptor tyrosine kinase signaling as a therapeutic targetMisregulation of pre-mRNA alternative splicing in cancerDefective control of pre-messenger RNA splicing in human diseaseThe role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionNonsense-mediated decay as a terminating mechanism for antisense oligonucleotides.A cytoplasmic quaking I isoform regulates the hnRNP F/H-dependent alternative splicing pathway in myelinating glia.A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.Variants affecting exon skipping contribute to complex traits.Identification of differential splicing genes in gliomas using exon expression profiling.Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy.Intron retention in the alternatively spliced region of RON results from weak 3' splice site recognition.Evolutionarily emerged G tracts between the polypyrimidine tract and 3' AG are splicing silencers enriched in genes involved in cancer.The RNA-binding protein QKI suppresses cancer-associated aberrant splicing.Identification of cis-acting elements and splicing factors involved in the regulation of BIM Pre-mRNA splicingTranscriptome-wide identification and study of cancer-specific splicing events across multiple tumors.SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.Global Profiling of the Cellular Alternative RNA Splicing Landscape during Virus-Host InteractionsTranscriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomasPost-transcriptional regulation in cancer progression : Microenvironmental control of alternative splicing and translation.Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression.RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.Targeting RNA splicing for disease therapy.SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.The prognostic potential of alternative transcript isoforms across human tumors.Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.RNA splicing factors as oncoproteins and tumour suppressors.Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).Splicing in oncogenesis and tumor suppression.Pre-mRNA splicing in disease and therapeutics.Aberrant splicing in neurological diseases.Alternative splicing in cancer: implications for biology and therapy.Alternative splicing of DNA damage response genes and gastrointestinal cancers.Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development
P2860
Q24302434-EB70CF7F-82D2-4D4F-A5CD-8AB0D426935BQ27001635-06F969D4-3DA9-4D15-BC59-61FB9684A392Q27003295-6DE16926-9E18-48BE-9937-48146D0B1CA0Q27007114-977B211B-DC10-42DD-97CF-63C3A9D80FC3Q28077564-24E805C6-DAF9-40D8-86A9-7EBB4785F70CQ28083838-DE4425F5-C852-4B27-BCCB-7C2ADC00DE36Q33635469-D2B46E00-6861-4EBA-A3A6-B8F5562FD6B3Q33791197-F38E23A2-B3FE-4A39-A17F-3DBA61B4BA35Q34037595-014B6A0D-EE62-4092-9903-8AC940F420F0Q34040857-A230DF2D-5A24-4519-A009-E739D98704B0Q34289536-D05C226C-F6BE-4B9D-A7F1-988A6F968994Q34469030-83802FEE-15D6-4C51-996F-07784E92747AQ34673613-8D240E71-93E1-4AE8-BC77-9D6D1BBCC275Q34911031-4039F7EB-C3BE-47C8-9E86-9A8C230D3148Q35025393-6E2576EF-AFC9-4F22-B6A4-62C86B507E3BQ35060560-FF695EC6-7862-4484-9BA1-0C248DACC501Q35145133-5224498B-5B17-4C90-B594-E21D6DE90EABQ35151577-A0AE5A5A-05C8-4D55-B768-49A2CD145341Q35740083-CFA4C087-1EE4-41A7-BE81-583C537238C4Q35949901-DF9290DE-C8FB-4232-8D9E-BABB42FFA271Q36124078-28AB83DB-3D44-4B86-8A6F-E94E2D103788Q36368952-A8912575-7481-4BC6-96D7-BA720FCD218DQ36398266-AEDCADC1-8364-4F3A-A0C2-5B480CAC1A8AQ36485156-176F3E26-3646-4103-83BF-35232D3DB23FQ36559726-5F086C26-43BC-4FAA-9022-26264B4667B4Q36780738-4761CB51-E319-4D9F-9AE4-0B504368E444Q36791562-0FDD2AD4-BFB7-46EA-8A78-A761903F6548Q36827111-3F007899-B8E1-4601-B3F5-38E769F02F0AQ36991152-BB7C0EDF-0FB9-441F-AB75-E86A5428E33EQ37185523-F798E4BF-91A1-42ED-BDA5-BA1306FF2F57Q37203277-700AAB64-115E-48D9-873B-821869C192A6Q37304724-14513270-4642-44FB-AE2B-5C1BAC558DABQ37391660-5217D89C-E70B-4FC1-A02C-02A96A96DF42Q37986326-0B776303-7750-4855-A2F7-1C66CC23353CQ38018123-8E189C80-7038-4E04-881F-F3BF70BD9649Q38028093-1166C57A-78FA-4008-A4DC-C0FC17105E5AQ38118935-ED3228A0-B594-431C-8E2D-6560B313E9AEQ38179828-F3D5826A-BCFA-4E29-AF22-01534387177EQ38291477-49D85B34-D5AB-41AC-8438-F03D3B23AAE4Q38487106-6D7319CA-E445-4F13-8DD9-C738B756C992
P2860
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
@en
type
label
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
@en
prefLabel
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
@en
P2093
P2860
P356
P1433
P1476
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
@en
P2093
Clare V Lefave
Eric C Holland
Gina L Rocco
Luca Cartegni
Sandra Vorlova
Ying-Xian Pan
P2860
P304
P356
10.1038/EMBOJ.2011.259
P407
P577
2011-09-13T00:00:00Z